Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Dermal Equivalent Engineered With Tgf-Β3 Expressing Bone Marrow Stromal Cells and Amniotic Membrane: Cosmetic Healing of Full-Thickness Skin Wounds in Rats Publisher Pubmed



Samadikuchaksaraei A1, 2, 3 ; Mehdipour A2 ; Habibi Roudkenar M4 ; Verdi J5 ; Joghataei MT1 ; Asadi K6 ; Amiri F4 ; Dehghan Harati M7 ; Gholipourmalekabadi M1, 2, 8 ; Karkuki Osguei N9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Cellular and Molecular Research Center, Iran University of Medical Sciences, Iran
  2. 2. Department of Tissue Engineering & Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Iran
  3. 3. Department of Medical Biotechnology, Faculty of Allied Medicine, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Medical Biotechnology, Faculty of Allied Medicine, Guilan University of Medical Sciences, Rasht, Iran
  5. 5. Department of Applied Cellular Sciences, Faculty of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Iran
  6. 6. Department of Plastic and Reconstructive Surgery, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
  7. 7. Translational Oncology, Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital Tuebingen, Tuebingen, Germany
  8. 8. Department of Medical Biotechnology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Iran
  9. 9. Eposcience Millennium Institute, Tehran, Iran

Source: Artificial Organs Published:2016


Abstract

Transforming growth factor beta-3 (TGF-β3) has been shown to decrease scar formation after scheduled topical applications to the cutaneous wounds. This study aimed to continuously deliver TGF-β3, during the early phase of wound healing, by engineering a dermal equivalent (DE) using TGF-β3 expressing bone marrow stromal cells (BM-SCs) and human dehydrated amniotic membrane (hDAM). To engineer a DE, rat BM-SCs were seeded on the hDAM and TGF-β3 was transiently transfected into the BM-SCs using a plasmid vector. Pieces of the dermal equivalent were transplanted onto the full-thickness excisional skin wounds in rats. The process of wound healing was assessed by image analysis, Manchester Scar Scale (MSS), and histopathological studies 7, 14, 21, and 85 days after the excision. The results confirmed accurate construction of recombinant pcDNA3.1-TGF-β3 expression system and showed that the transfected BM-SCs seeded on hDAM expressed TGF-β3 mRNA and protein from day 3 through day 7 after transfection. After implantation of the DE, contraction of the wounds was measured from day 7 through 21 and analyzed by linear regression, which revealed that the rate of wound contraction in all experimental groups was similar. Histologic evaluation demonstrated that transfected BM-SCs decreased retention and recruitment of the cells during the early stage of wound healing, decreased the formation of vascular structures and led to formation of uniformly parallel collagen bundles. MSS scores showed that TGF-β3 secreting cells significantly improved the cosmetic appearance of the healed skin and decreased the scar formation. From these results, it could be concluded that transient secretion of TGF-β3, during the early phase of healing, by BM-SCs seeded on hDAM can improve the cosmetic appearance of the scar in cutaneous wounds without negatively affecting the process of wound repair. Copyright © 2016 International Center for Artificial Organs and Transplantation and Wiley Periodicals, Inc.
Other Related Docs
11. Oxygen-Generating Nanobiomaterials for the Treatment of Diabetes: A Tissue Engineering Approach, Nanobiomaterials in Soft Tissue Engineering: Applications of Nanobiomaterials (2016)